Canada markets open in 2 hours 55 minutes

Radient Technologies Inc. (RTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1350-0.0100 (-6.90%)
At close: 2:49PM EDT
Full screen
Previous Close0.1450
Open0.1400
Bid0.1350 x N/A
Ask0.1400 x N/A
Day's Range0.1300 - 0.1450
52 Week Range0.1250 - 0.8000
Volume524,626
Avg. Volume740,775
Market Cap42.522M
Beta (5Y Monthly)1.70
PE Ratio (TTM)N/A
EPS (TTM)-0.1000
Earnings DateAug. 31, 2020 - Sep. 04, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Radient Technologies Inc. Provides Update on Filing of Year-End Financial Statements

    EDMONTON, Alberta, July 27, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), announces that the Company will be relying on the temporary 45 day extension to the filing deadline of its annual financial statements and management’s discussion and analysis (“MD&A”) for the year ended March 31, 2020 granted by the Alberta Securities Commission (“ASC”) in response to unprecedented challenges resulting from COVID-19. The notice released states that securities regulators will be providing coordinated relief consisting of a 45-day extension for certain periodic filings required to be made on or prior to August 31, 2020 as a result of the COVID-19 pandemic.As per National Instrument 51-102 Continuous Disclosure Obligations, the Company was to file its annual financial statements and MD&A by July 29, 2020. Relying on ASC Blanket Order 51-519, which provides the Company with an additional 45 days from the deadline to file, the Company expects to file its annual financial statements and MD&A on or before September 14, 2020.All material business developments since the date of the Company’s filing of its interim financial statements and MD&A for the period ended December 31, 2019 have been disclosed.The Company acknowledges that management and other insiders are subject to an insider trading black-out policy, that reflects the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, until the second trading day after the Annual Filings have been disclosed.About Radient Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.SOURCE: Radient Technologies Inc.For further information please contact:Radient - Investor Relations, ir@radientinc.comForward Looking Information: This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding Company’s reliance on ASC Blanket Order 51-519; and the Company’s annual financial statements and MD&A. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

  • GlobeNewswire

    Radient Technologies Inc. and Fluum Inc. Enter Into Multi-Year White Label Deal

    EDMONTON, Alberta, July 27, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, is pleased to announce a five year white-label agreement with Fluum Inc. (“Fluum”), to launch a line of cannabis vape products designed to deliver enhanced experiences at a competitive price.  Radient will provide a full suite of services; using its proprietary extraction technology to provide cannabis extracts, along with filling, packaging, and sales distribution.  Led by cannabis industry veterans, Fluum will be responsible for design, marketing and driving consumer awareness.  Under the terms of the five-year agreement, Radient will manufacture a minimum of 210,000 units in the first year, growing to a minimum of 240,000 units in each subsequent year, subject to orders from provincial distributors.  Through its relationships with established cannabis retailers, Fluum has already secured letters of intent from a multi-province retail group and a Saskatchewan distributor, together representing nearly 50 retail locations in 4 provinces to purchase products once they become available.  Radient holds all necessary licensing and is currently expanding its vape filling line.  First sales of Fluum branded products are anticipated in Q4 of 2020."Our mission at Fluum is to help develop innovative, reliable, and cost effective cannabis products that enhance the wellbeing of the cannabis user," said Adam Flook, President of Fluum.  "I have spent the past six years working with cannabis retailers in both Canada and the US, watching the evolution of products and consumer preferences.  We have been impressed by Radient's ability to produce high quality extracts and the level of consistency, which made them a natural choice as a partner."“Radient is excited to be partnering with a group of highly experienced cannabis entrepreneurs in our first white label agreement for vape products,” said Denis Taschuk, CEO of Radient. “The Fluum team has invested the time to understand consumer preferences, collect feedback from retailers, and has had the benefit of monitoring the sales and quality of current offerings.  We will be bringing together Fluum’s vision and knowledge with Radient’s high quality extracts to create an exceptional line of products.”About FluumFluum specializes in the cannabis retail industry.  Over the last 6 years they have developed a thorough understanding of quality product and consumer trends.  Through their partnerships Fluum has developed an extensive distribution network in excess of 60 cannabis retail locations.  Fluum will play an integral part in developing innovative new products that enhance the wellbeing of its consumers.  Visit www.fluum.ca for more info.About Radient Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.SOURCE: Radient Technologies Inc.For further information please contact:Fluum - info@fluum.ca Radient - Investor Relations, ir@radientinc.comForward Looking Information: This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the agreement with Fluum and the Company’s ability to perform its obligations pursuant to such agreement; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

  • GlobeNewswire

    Radient Technologies Inc. Announces Participation in a Medical Cannabis Study Led by the University Health Network in Partnership with Shoppers Drug Mart

    EDMONTON, Alberta, July 17, 2020 -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based.